Learning Objectives:

• Recognize time-sensitive urologic emergencies
• Competently initiate patient stabilization
• Discern when to consult urology immediately

Andrew J. Hamilton, DO (he/him/his), Family Medicine Residency Core Faculty, Henry Ford Genesys

Learning Objectives:

• Recognize and initiate urgent management of TTP, ITP, and HIT, including key diagnostic features and indications for hematology consultation. Use guideline-based red blood cell and platelet transfusion thresholds in common hospitalized patient scenarios.
• Apply evidence-based approaches to the inpatient diagnosis and management of DVT and PE, including anticoagulation selection and risk stratification.
• Identify clinical and laboratory findings suggestive of acute leukemia (AML/ALL) and outline appropriate initial inpatient evaluation and stabilization.

Stephanie A. Haddad, DO (she/her/hers), Hematology/Oncology Fellow , PGY-5, UT Health San Antonio/Mays Cancer Center

Learning Objectives:

• Hypercalcemia in malignancy.
• Tumor Lysis Syndrome in malignancy.
• Adrenal insufficiency in malignancy Hypoglycemia in malignancy Hyponatremia in malignancy Lactic Acidosis in malignancy.

Peter Lamie, DO, Onco-hospitalist, University of Texas - MD Anderson Cancer Center

Learning Objectives:

• Learn the evolution of immunotherapy drug development and the pathophysiology of immune related adverse events (iRAE)
• Understand the timeline of the developement of iRAEs with major immunotherapy treatments how how to triage severity.
• Perform a comprehensive patient assessment for iRAEs, grading of toxicity and treatment considerations in hospitalized patients.

Joseph W. McCollom, DO (he/him/his), Oncologist, Parkview Packnett Family Cancer Institute / Parkview Physicians Group / Parkview Health

Learning Objectives:

• Medication Management Is the Most Modifiable Risk Factor, majoirty of inflammatory arthritis patients are on DMARDs and biologics at time of surgery. Optimizing these agents — especially minimizing glucocorticoids — is the most accessible and impactful preoperative intervention.
• Recognize Diagnosis-Specific Complication Patterns AS: pulmonary compromise from chest wall restriction → highest pneumonia risk. PsA: comorbidities and obesity drive adverse events, not disease activity. RA: infection remains the most concerning adverse event.
• Implement the Guideline Framework with Nuance ACR guideline recommendations are all conditional — no RCT data exist. Confounding by indication and publication bias limit certainty. Individualized, shared decision-making between rheumatologist, surgeon, and patient is paramount.

Rubaiya Mallay, DO, FACOI, FACR (she/her/hers), Rheumatologist, Suncoast Internal Medicine Consultants

Learning Objectives:

• Upon completion, participants will be able to:
  • Understand the four components of Osteopathic Continuous Certification (OCC).
  • Identify subspecialties certified by the American Osteopathic Board of Internal Medicine.
  • Readily share information with others regarding Osteopathic Continuous Certification (OCC).

J. Rico Blanco, MSHA (he/him/his), Certification Director, American Osteopathic Board of Internal Medicine